News and Comments

Halozyme's PEGPH20 Trial Results Are Worth Appreciating Not Doubting

  Friday, January 06, 2017

Extremely important, not just exciting, were the results of Halozyme Therapeutics’s (HALO) Phase 2 randomized, multi-center clinical trial of its PEGPH20 in combination with ABRAXANE® (nab-paclitaxel) and gemcitabine in stage IV pancreas cancer.  More...

HALOZYME: FINANCING PEGPH20 IS WORTH RAISING MONEY

  Wednesday, February 05, 2014

Halozyme Therapeutics (HALO) stock has been a loser yesterday while other biotech firms have rebounded after dipping during the few days’ of an angry market. The reason for the stock decline was the announcement of pricing of Halozyme’s previously announced underwritten public offering of 7,692,307 shares of its common stock at a public offering price of $13.00 per share.  More...


Recent Postings


Archive


Tags

Advaxis (ADXS) Illumina (ILMN) AGOS (ARGS) Micromet (MITI) Ionis (IONS) Abbott Laboratories (ABT) Dynavax (DVAX) Incyte (INCY) SUNESIS PHARMACEUTICALS (SNSS) Vertex (VRTX) Human Genome Sciences (HGSI) Ziofpharm (ZIOP) Ariad (ARIA) CRISPR Therapeutics (CRSP) Merck (MRK) Tysabri Roche (RHHBY) Velcade (bortezomib) ISIS (ISIS) PORTOLA (PTLA) Adaptimmune (ADAP) TOKAI (TKAOI) GlaxoSmithKline (GSK) Sanofi (SNA) Onyx (ONXX) AERIE PHARMACEUTICALS NEKTAR (NKTR)) RenenxBio (RGNX) Amgen (AMGN) Auspex (ASPX) ZALTRAP™ Dendreon (DNDN) C4 Therapeutics Valeant Pharmaceuticals International (VRX) BIOMARIN (BMRN) Sanofi-Aventis (SAN) JUNO (JUNO) Elan (ELN) Galena (GALE) Agenus (AGEN Cytokinetics (CYTK) HALOZYME (HALO) ImmunoGen (IMGN) PTC Therapeutics (PTCT) Editas (EDIT) GUARDIAN HEALTH Inovio (INO) Theravance Bio Pharma (TBPH) Roche (ROCHE) Prolor Biotech (PBTH) Intercept (ICPT) ABBVIE (ABBV) Revlimid (lenolidamide) Spike Therapeutics (ONCE) ARGOS (ARGS) REGULUS (RGLS) Zerenex NANTKWEST (NK) NOVOCURE (NVCR) Vitae Pharmaceuticals (VTAE) Biocryst (BCRX) Xoma (XOMA) Array Pharmaceuticals (ARRY) Ocular Therapeutix (OCUL) Idenix (IDIX) Rapamune KITE (KITE) MODERNA Prosensa (RNA) Intermune (ITMN) Regeneron (REGN) ARCA (ABIO) VANDA (VNDA) galapagos (GLPG) KERYX (KERX) CompuGen (CGEN) Biogen Idec (BIIB) Gilead (GILD) Seattle Genetics (SGEN) Mirati Therapeutics (MRTX) Bristol-Myers Squibb (BMY) Sangamo (SGMO) Jazz Pharmaceuticals (JAZZ) Multiple Myeloma Exelixis (EXEL) SYNTA (SNTA) Herceptin CEMPRA (CEMP) INNOVIVA (INVA) Theravance (THRX) Ridaforolimus Global Cell Therapeutics (GBT) Alnylam (ALNY) Anadys (ANDS) Trastuzumab-DM1 Pluristem (PSTI) OSI (OSIP) Agenus (AGEN) Human Longevity (HLI) Anacor (ANAC) Alder Biopharmaceuticals (ALDR) Sarepta (SRPT) Aimmune Therapeutics (AIMT) SERES THERAPEUTICS (MCRB) Benlysta (belimumab) Endometrial Cancer Bellicum (BLCM) Sanofi (SNY) Genentech IDERA (IDRA) AstraZeneca (AZN) Intrexon (XON) Sequenom (SQNM) ADVENTRIX (ANX) Telaprevir ACADIA (ACAD)